Thyrocare Technologies Ltd. News and Updates

Name: Latest research reports of Thyrocare Technologies Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Thyrocare Technologies Ltd.
Rating: 4
Author: ICICI Securities Limited

Keep track of all breaking news on Thyrocare Technologies Ltd. from all sources in a single place.

Load latest

Thyrocare Technologies Ltd.

01 Feb 2024

700.25

3.67%

Thyrocare Technologies Results Earnings Call for Q3FY24

Conference Call with Thyrocare Technologies Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Thyrocare Technologies Ltd.

14 Dec 2023, 12:33PM

700.25

3.67%

Thyrocare Technologies share price may see 20% upside; ICICI Securities upgrades stock, raises target price

livemint

ICICI Securities has upgraded Thyrocare Technologies stock to Buy' from Add; earlier and raised the target price to 740 per share from 615.

Thyrocare Technologi.. has an average target of 825.00 from 1 broker.

Thyrocare Technologies Ltd.

13 Dec 2023, 01:52PM

700.25

3.67%

Buy Thyrocare Technologies; target of Rs 740: ICICI Securities

Moneycontrol

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

Thyrocare Technologies Ltd. has lost -27.09% in the last 3 Months

Thyrocare Technologies Ltd.

01 Nov 2023

700.25

3.67%

Thyrocare Techn Consolidated September 2023 Net Sales at Rs 148.00 crore, up 9.65% Y-o-Y

Moneycontrol

Number of FII/FPI investors increased from 66 to 77 in Dec 2024 qtr.

Thyrocare Technologies Ltd.

01 Nov 2023

700.25

3.67%

Operations revitalising; mounting debt a concern

Accumulate: Thyrocare Technologies Ltd.

Target

ICICI Securities Limited

Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.

Number of FII/FPI investors increased from 66 to 77 in Dec 2024 qtr.

Thyrocare Technologies Ltd.

31 Oct 2023

700.25

3.67%

Thyrocare Technologies Results Earnings Call for Q2FY24

Conference Call with Thyrocare Technologies Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Thyrocare Technologies Ltd.

03 Aug 2023

700.25

3.67%

Thyrocare Technologies shares dip on weak Q1 results

Business Line

Thyrocare Technologies reports 20% decline in profit for June quarter

Number of FII/FPI investors increased from 66 to 77 in Dec 2024 qtr.

Thyrocare Technologies Ltd.

02 Aug 2023

700.25

3.67%

Thyrocare Tech tumbles 3% on weak Q1 earnings show

Moneycontrol

Thyrocare Tech attributed the growth slowdown to a closure of the contract from Municipal Corporation of Greater Mumbai (MCGM) and a dip in its API (Active Pharmaceutical Ingredients) business

Number of FII/FPI investors increased from 66 to 77 in Dec 2024 qtr.

Thyrocare Technologies Ltd.

02 Aug 2023

700.25

3.67%

Revamping business model to restore margins

Accumulate: Thyrocare Technologies Ltd.

Recommendation Target

ICICI Securities Limited

Thyrocare Technologies has reported an improvement in gross margin (+270bps YoY) in Q1FY24 led by a decline in low margin partnership business. The company has revamped incentive structure offered to franchisees and this should drive a strong 12-14% volume growth in this segment.

Number of FII/FPI investors increased from 66 to 77 in Dec 2024 qtr.

Thyrocare Technologies Ltd.

05 Jul 2023

700.25

3.67%

Manipal Group offers to inject Rs 1,000 cr in PharmEasy owner API Holdings: Report

Business Today

It is important to note that API Holdings has to repay a debt of Rs 2,500 crore. Previously, the company had pledged the shares of its subsidiary Thyrocare to Goldman Sachs as collateral for this debt.